1. Home
  2. NEPH vs ARAY Comparison

NEPH vs ARAY Comparison

Compare NEPH & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

N/A

Current Price

$3.24

Market Cap

39.0M

Sector

Health Care

ML Signal

N/A

Logo Accuray Incorporated

ARAY

Accuray Incorporated

N/A

Current Price

$0.14

Market Cap

31.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEPH
ARAY
Founded
1997
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.0M
31.3M
IPO Year
2004
2006

Fundamental Metrics

Financial Performance
Metric
NEPH
ARAY
Price
$3.24
$0.14
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $6.25
N/A
AVG Volume (30 Days)
54.8K
★ 1.9M
Earning Date
11-05-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 1000.00
87.50
EPS
★ 0.12
N/A
Revenue
★ $18,789,000.00
N/A
Revenue This Year
$17.81
$2.75
Revenue Next Year
$15.90
$2.35
P/E Ratio
$27.33
★ N/A
Revenue Growth
★ 32.67
N/A
52 Week Low
$2.66
$0.12
52 Week High
$6.42
$1.46

Technical Indicators

Market Signals
Indicator
NEPH
ARAY
Relative Strength Index (RSI) 36.24 39.00
Support Level $3.15 $0.12
Resistance Level $3.18 $0.29
Average True Range (ATR) 0.23 0.01
MACD -0.02 0.00
Stochastic Oscillator 12.41 48.33

Price Performance

Historical Comparison
NEPH
ARAY

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

Share on Social Networks: